Danny Bartlett is a Consultant Pharmacist, NHS England Clinical Lead, and one of the UK's most sought-after primary care speakers — driving better medicines, better teams, and better patient outcomes.
Danny Bartlett is a national Key Opinion Leader and Consultant Pharmacist operating at the intersection of medicines optimisation, prescribing policy, workforce education, and healthcare strategy. As Clinical Lead for the Kent, Surrey & Sussex Primary Care School (NHS England), he holds regional oversight of a £3.16m training budget, directing multi-professional education across three Integrated Care Boards serving a combined population of 3.5 million.
A former elected Board Member of the English Pharmacy Board (Royal Pharmaceutical Society, 2023–2026) and current Panel Member for the General Pharmaceutical Council's national accreditation process, Danny contributes at the highest levels of professional governance. He is also Deputy Course Lead and Senior Lecturer in Pharmacist Independent Prescribing at the University of Brighton, and co-author of a forthcoming book on medicines management in primary care (Class Professional, June 2026).
With a publishing record spanning BMJ Open, the Pharmaceutical Journal, and Chemist & Druggist, Danny combines academic rigour with the practical credibility of over a decade on the front line of primary care.
From workforce strategy to conference keynotes, I offer evidence-based support tailored to primary care organisations, PCNs, ICBs, and professional bodies.
Engaging, evidence-led keynotes and workshops at national and regional events — from Best Practice and Clinical Pharmacy Congress to local ICB forums and PCN away days.
View topics →Bespoke education sessions covering medicines optimisation, prescribing best practice, and high-risk drug management — built on academic expertise and frontline primary care experience.
Enquire →Supporting PCNs, ICBs and Training Hubs to develop their pharmacy and multi-disciplinary workforce — from ARRS recruitment strategy to DPP quality assurance and education planning.
Enquire →Working with practices and PCNs to identify improvement opportunities, implement medicines-related service redesign, and measure meaningful patient outcomes — proven to reduce GP contact demand.
Enquire →Supporting practices with structured medication review governance, high-risk medicines frameworks, and clinical audit programmes aligned to CQC standards and NHS England policy.
Enquire →One-to-one mentoring for pharmacists and allied health professionals navigating new primary care roles — accredited CCG coach/mentor helping clinicians build capability, clarity, and career confidence.
Enquire →Evidence-led, practically grounded sessions that resonate with primary care audiences — from frontline prescribers to ICB medicines leads and pharmacy educators.
Evidence-based strategies for reducing inappropriate polypharmacy, improving patient safety, and building a sustainable deprescribing culture across primary care networks.
How prescribers can bridge the gap between national guidance and everyday practice — with practical tools for cardiovascular risk reduction and SGLT-2/GLP-1 optimisation.
Moving beyond medicines management to truly transform patient care — a strategic and practical guide for pharmacy professionals operating in PCN and general practice settings.
A case-study-led exploration of how primary care teams can design robust governance frameworks for high-risk drugs and prevent avoidable harm.
What the 2026 prescribing registration changes mean for the profession — and how educators, employers, and clinical leads can prepare their organisations.
A practical QI toolkit for busy primary care teams — stripping out the jargon and focusing on the methods that drive sustainable, measurable improvement in under-resourced settings.
Previous speaking venues include
Looking for a speaker for your next event? I'd love to discuss a bespoke session for your audience.
Feedback from clinicians, event organisers, and organisations across primary care.
"Danny's session at our PCN away day was outstanding. He has a real gift for making complex clinical topics accessible and genuinely energising for the whole team."
"The quality improvement programme Danny led transformed how we approach medicines reviews. Practical, evidence-based and genuinely impactful — we saw measurable reductions in GP demand within months."
"One of the most engaging and knowledgeable speakers on the primary care conference circuit. Always leaves the audience with something they can put into practice the very next day."
Published academic work, clinical commentary, and thought leadership across primary care pharmacy, medicines optimisation, and workforce development.
A practical, clinician-facing reference guide for allied health professionals working in primary care settings. Covering medicines optimisation, safe prescribing, high-risk drugs, and structured medication review, this book equips pharmacists, nurses, and AHPs with the tools they need for confident, evidence-based medicines management in general practice and PCNs.
Pre-order on Class Professional →
A national modified Delphi consensus study involving 201 UK healthcare professionals — GPs, pharmacists, and sleep specialists — generating 37 evidence-based recommendations to improve the diagnosis and management of chronic insomnia in primary care. The study highlights systemic under-recognition of insomnia and calls for it to be treated as a stand-alone chronic condition.
Steering group member & co-author
An inside account of the expanding and evolving role of clinical pharmacists within primary care networks — demystifying the day-to-day reality of PCN pharmacy practice and making the case for the profession's central role in delivering NHS primary care transformation.
AuthorReporting on the significant clinical impact of structured medication reviews (SMRs) conducted by clinical pharmacists in primary care, demonstrating measurable reductions in potentially inappropriate prescribing and highlighting the value of pharmacist-led interventions in reducing medicines-related harm.
ContributorCalling for robust governance, clinical supervision, and professional support structures as increasing numbers of pharmacists move into general practice. Sets out what safe, effective ARRS pharmacy workforce integration requires — from competency frameworks to leadership accountability.
AuthorA frontline account of the medicines-related pressures facing primary care during the COVID-19 pandemic — exploring how media-driven patient anxieties around medication generated a wave of inappropriate requests and what pharmacists and GPs can do to manage demand safely and compassionately.
AuthorWhether you're looking for a conference speaker, clinical educator, QI partner, or workforce consultant — I'd love to hear about your project. Fill in the form or reach out directly.